Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
10/01/2009 | CA2719601A1 A composition for stabilizing .beta.-blocker and transdermally absorbable preparation comprising the same |
10/01/2009 | CA2719577A1 Use of ferritin to treat iron deficiency disorders |
10/01/2009 | CA2719246A1 Stabilizing lipid compositions for oral pharmaceutical agents |
10/01/2009 | CA2718780A1 Improved topical ophthalmic compositions |
10/01/2009 | CA2718755A1 Ketoprofen lysine salt-containing aqueous patch |
10/01/2009 | CA2718093A1 Ptph1 inhibitors for the treatment of alzheimer's disease |
10/01/2009 | CA2712535A1 An anti-cancer cytotoxic monoclonal antibody |
09/30/2009 | EP2105448A2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
09/30/2009 | EP2105146A1 Nucleic-acid triggered release of molecules |
09/30/2009 | EP2105145A1 Method for muscle-specific delivery lipid-conjugated oligonucleotides |
09/30/2009 | EP2105144A1 Chitosan solution and medical preparation with chitosan coating formed from the solution |
09/30/2009 | EP2105143A1 Pharmaceutical compositions based on salts of tiotropium and ciclesonide |
09/30/2009 | EP2105133A1 Intragastric floating-type levodopa sustained-release preparation |
09/30/2009 | EP2104740A2 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
09/30/2009 | EP2104732A1 Cancerous disease modifying antibodies |
09/30/2009 | EP2104519A2 Film-forming gel composition for wound or skin care |
09/30/2009 | EP2104515A2 Method for preparing a polymer conjugate |
09/30/2009 | EP2104498A2 Liquid formulations of phospholipase enzyme inhibitors |
09/30/2009 | EP2104488A2 Gas-filled microvesicles with targeting ligand in respect of fc-region of an antibody or therapeutic agent |
09/30/2009 | EP2104428A2 Combination product for controlling parasites on animals |
09/30/2009 | EP2104426A1 Agents for controlling parasites on animals |
09/30/2009 | EP1530465B1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
09/30/2009 | EP1507859B1 Fusion proteins of humanized g250 specific antibodies and uses thereof |
09/30/2009 | EP1476130B1 Use of specific diols for reducing the viscosity of cosmetic and/or dermatologic compositions |
09/30/2009 | EP1471892B1 Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
09/30/2009 | EP1404300B1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
09/30/2009 | EP1349549B1 Novel medicament compositions based on salts of tiotropium and on ciclesonide |
09/30/2009 | EP1328297B1 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
09/30/2009 | EP1261347B1 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
09/30/2009 | EP1242122B1 Delivery of proteins across polar epithelial cell layers |
09/30/2009 | EP1037649B1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
09/30/2009 | EP0938338B1 Carrier composition for influencing the tight junction permeability |
09/30/2009 | CN101544756A Biological adhesion-type polyethyleneglycol derivative and application thereof in pharmacology |
09/30/2009 | CN101544696A Compound containing pigment epidermal derived factors and preparation method and application thereof |
09/30/2009 | CN101544638A Lact-pyrondridin and its pharmaceutical composition |
09/30/2009 | CN101543632A Anti-tumor prodrug having accurate structure and taking novel amphipathic polymer as carrier and synthetic method thereof |
09/30/2009 | CN101543631A Microspherical substrate containing beeswax, pharmaceutical composition containing microspherical substrate and application thereof |
09/30/2009 | CN101543630A Preparation and application of amphiphilic albumin derivative and pharmaceutical composition thereof |
09/30/2009 | CN101543629A Application of papaverine hydrochloride as transdermal absorption enhancer |
09/30/2009 | CN101543603A Chinese medicinal granule for treating endometriosis uterine and preparation method thereof |
09/30/2009 | CN101543600A Acarid killing gel and preparation method thereof |
09/30/2009 | CN101543596A Traditional Chinese medicine composition for curing sciatica and preparation method thereof |
09/30/2009 | CN101543584A Chinese patent drug for treating gastric ulcer |
09/30/2009 | CN101543571A Rhizoma paridis total aglycone sustained-release pellet as well as preparation method and application thereof |
09/30/2009 | CN101543570A Smilax glabra total aglycone oral pharmaceutical preparation as well as preparation method and application thereof |
09/30/2009 | CN101543568A Yam total sapogenin sustained-release pellet as well as preparation method and application thereof |
09/30/2009 | CN101543563A Vein-relaxing bone-nourishing osteophyte-eliminating ointment and method for preparing same |
09/30/2009 | CN101543549A Chinese lizardtail flavone dripping pill |
09/30/2009 | CN101543548A Chinese lizardtail flavone quick release preparation |
09/30/2009 | CN101543539A Chinese medicinal plaster for treating infantile anorexia and indigestion |
09/30/2009 | CN101543529A Clinopodium polycephalum total aglycone sustained-release pellet as well as preparation method and application thereof |
09/30/2009 | CN101543528A Clinopodium polycephalum total aglycone oral pharmaceutical preparation as well as preparation method and application thereof |
09/30/2009 | CN101543526A Kudzu root total aglycone sustained-release pellet as well as preparation method and application thereof |
09/30/2009 | CN101543520A Blumea oil liquid capsule and preparation method thereof |
09/30/2009 | CN101543518A Ginseng stem leaf total sapogenin oral pharmaceutical preparation as well as preparation method and application thereof |
09/30/2009 | CN101543517A Folium ginkgo total flavonoid aglycone sustained-release pellet as well as preparation method and application thereof |
09/30/2009 | CN101543511A Pressed pharmaceutical composition containing medicinal charcoal and polyethyleneglycol |
09/30/2009 | CN101543509A Ophthalmic gel containing chondroitin sulfate and method for preparing same |
09/30/2009 | CN101543503A Partial compound erythrocin zinc acetate gelling agent and preparation method thereof |
09/30/2009 | CN101543501A Balsatazide sodium enema liquid and preparation method thereof |
09/30/2009 | CN101543493A (SBA-15)-nimodipine medicament and preparation method thereof |
09/30/2009 | CN101543486A Application of tetrahydrocurcumin in preparing antidepressant and method for preparing solid dispersion of tetrahydrocurcumin |
09/30/2009 | CN101543483A Sinetipin capsule and preparation method and quality detection method thereof |
09/30/2009 | CN101543482A Nano calcium carbonate enteric-coated bioadhesive tablets and their preparation method |
09/30/2009 | CN101543480A Tablets |
09/30/2009 | CN101543478A Boanmycin freeze-dry powder injection and preparation method thereof |
09/30/2009 | CN101543477A Sustained-release microsphere of chitosan-coated 3,5-dihydroxy-4-isopropyl toluylene and preparation method thereof |
09/30/2009 | CN101543476A A naringin solid dispersion and the preparation method, and the application thereof |
09/30/2009 | CN101543475A Tiamulin fumarate for veterinary use, lung-targeting microsphere of tiamulin fumarate salt and preparation method thereof |
09/30/2009 | CN101543474A Lansoprazole sodium submicron emulsion freeze-drying preparation |
09/30/2009 | CN101543472A Method for preparing oxaliplatin sustained release suppository |
09/30/2009 | CN101543471A Rumen glucose |
09/30/2009 | CN100544770C Method for detecting and killing epithelial cancer cells |
09/30/2009 | CN100544769C Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation |
09/30/2009 | CN100544768C Hydrogenated castor oil nano-lipophilic medicine preparation and preparation method thereof |
09/30/2009 | CN100544767C Use of chitosan oligosaccharide and its chitosan oligosaccharide iron complex as anti HIV-1 polypeptide drug carrier |
09/30/2009 | CN100544766C Matrix for Chinese medicine plaster and its preparation process |
09/30/2009 | CN100544725C Androgen pharmaceutical composition and method for treating depression |
09/30/2009 | CN100544714C Composition for solubilization of paclitaxel and preparation method thereof |
09/30/2009 | CN100544713C Paclitaxel mixed composition and water-in-oil type emulsion formulation for chemoembolization and preparation method thereof |
09/29/2009 | US7595411 Transferring drugs; antitumor agents, anticancer agents |
09/29/2009 | US7595394 Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier |
09/29/2009 | US7595318 Conjugates which bind VLA-4; may also inhibit leukocyte adhesion; useful in the treatment of inflammatory diseases in a mammalian patient, such as asthma, Alzheimer's disease, atherosclerosis, AIDS, dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis |
09/29/2009 | US7595292 Conjugated biological molecules and their preparation |
09/29/2009 | US7595052 Composition and method for the prevention and/or the treatment of allergy |
09/29/2009 | US7595044 Artery-and vein-specific proteins and uses therefor |
09/29/2009 | CA2498457C Composition for treating hemorrhoids |
09/29/2009 | CA2458474C Zwitterionic lipid compound and uses thereof |
09/29/2009 | CA2446741C Ophthalmic drug delivery device |
09/29/2009 | CA2390295C A method for chemoprevention of prostate cancer |
09/29/2009 | CA2376367C Liquid composition for topical application |
09/29/2009 | CA2347105C Controlled-release pharmaceutical composition with gastric residence |
09/29/2009 | CA2346862C Anionic-cationic polyion complexes comprising zwitterionic monomer component |
09/29/2009 | CA2313372C Composition and method for prolonging the useful life of enteral feeding tubes |
09/29/2009 | CA2310850C A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia |
09/29/2009 | CA2268474C Ester-terminated polyamide gels |
09/29/2009 | CA2259148C Solid oral dosage forms of valsartan |
09/29/2009 | CA2194660C Growth differentiation factor-11 |
09/29/2009 | CA2184297C Recombinant viruses coding for a glutamate decarboxylase (gad) activity |